Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alberto Ghiglieri, Monica Messina, Valentina Cenacchi, Claudia Piutti, Flavio Cinato, Giandomenico Brogin & Paola Puccini. (2023) ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties. Xenobiotica 53:4, pages 288-308.
Read now
Read now
S. Cyrus Khojasteh, Upendra A. Argikar, Sungjoon Cho, Rachel Crouch, Carley J. S. Heck, Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, Hlaing (Holly) Maw, Herana Kamal Seneviratne, Shuai Wang, Cong Wei, Donglu Zhang & Klarissa D. Jackson. (2022) Biotransformation novel advances – 2021 year in review. Drug Metabolism Reviews 54:3, pages 207-245.
Read now
Read now
Nuggehally R. Srinivas. (2016) Interspecies scaling of excretory amounts using allometry – retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine, cabotegravir, and dolutegravir for fecal excretion. Xenobiotica 46:9, pages 784-792.
Read now
Read now
Mario Pellegatti. (2014) The debate on animal ADME studies in drug development: an update. Expert Opinion on Drug Metabolism & Toxicology 10:12, pages 1615-1620.
Read now
Read now
Mario Pellegatti. (2013) Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing. Expert Opinion on Drug Metabolism & Toxicology 9:9, pages 1171-1180.
Read now
Read now
R. Scott Obach, Angus N. Nedderman & Dennis A. Smith. (2013) A response to “radiolabelled mass-balance excretion and metabolism studies in laboratory animals: a commentary on why they are still necessary”. Xenobiotica 43:2, pages 226-227.
Read now
Read now
Articles from other publishers (29)
Graeme C. Young, Douglas K. Spracklin, Alexander D. James, Mette G. Hvenegaard, Graeme Scarfe, David S. Wagner, Katrin Georgi, Hanno Schieferstein, Inga Bjornsdottir, Bianca van Groen, Andrea A. Romeo, Kenneth C. Cassidy, Georges Da‐violante, Bojan Bister, Stefan Blech, Ramaswamy Lyer, Simone I. Schulz, Filip Cuyckens & Patricia Moliner. (2022)
Considerations for Human
ADME
Strategy and Design Paradigm Shift(s) – An Industry White Paper
. Clinical Pharmacology & Therapeutics 113:4, pages 775-781.
Crossref
Crossref
Matthew A. Cerny, Douglas K Spracklin & R. Scott Obach. (2023) Human Absorption, Distribution, Metabolism and Excretion Studies - Origins, Innovations and Importance. Drug Metabolism and Disposition, pages DMD-MR-2022-001006.
Crossref
Crossref
Wei Tong, Rose Huang, Ruediger Narbe & Laura Letendre. 2023. Equine Science - Applications and Implications of New Technologies [Working Title]. Equine Science - Applications and Implications of New Technologies [Working Title].
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development
137
174
.
Biplab Das & Chandra Prakash. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1
21
.
Pedro Duque, Cristina P. Vieira & Jorge Vieira. (2022) Advances in Novel Animal Vitamin C Biosynthesis Pathways and the Role of Prokaryote-Based Inferences to Understand Their Origin. Genes 13:10, pages 1917.
Crossref
Crossref
Valerie M. Kramlinger, Deepak Dalvie, Carley J.S. Heck, Amit S. Kalgutkar, James O’Neill, Dian Su, Aaron M. Teitelbaum & Rheem A. Totah. (2022) Future of Biotransformation Science in the Pharmaceutical Industry. Drug Metabolism and Disposition 50:3, pages 258-267.
Crossref
Crossref
Anhye Kim, Stephen R. Dueker, Jun Gi Hwang, Jangsoo Yoon, Sang‐Won Lee, Hye Suk Lee, Byung‐Yong Yu, Kyung‐Sang Yu & Howard Lee. (2020) An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans. Clinical and Translational Science 14:1, pages 231-238.
Crossref
Crossref
Collin T. Inglut, Aaron J. Sorrin, Thilinie Kuruppu, Shruti Vig, Julia Cicalo, Haroon Ahmad & Huang-Chiao Huang. (2020) Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials 10:2, pages 190.
Crossref
Crossref
Reese Hitchings & Libusha Kelly. (2019) Predicting and Understanding the Human Microbiome’s Impact on Pharmacology. Trends in Pharmacological Sciences 40:7, pages 495-505.
Crossref
Crossref
Ryan H. Takahashi, Jae H. Chang, Jodie Pang, Xiaorong Liang & Shuguang Ma. (2019) Unequal Absorption of Radiolabeled and Nonradiolabeled Drug from the Oral Dose Leads to Incorrect Estimates of Drug Absorption and Circulating Metabolites in a Mass Balance Study. Drug Metabolism Letters 13:1, pages 37-44.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium- and Tritium-Labelled Compounds: Applications in the Life Sciences. Angewandte Chemie International Edition 57:7, pages 1758-1784.
Crossref
Crossref
Jens Atzrodt, Volker Derdau, William J. Kerr & Marc Reid. (2018) Deuterium- und tritiummarkierte Verbindungen: Anwendungen in den modernen Biowissenschaften. Angewandte Chemie 130:7, pages 1774-1802.
Crossref
Crossref
Yong Gong, Jie Chen, Yifan Shi, Heng-Keang Lim, Naidong Weng & Rhys Salter. (2017) Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application. Analytical Chemistry 89:16, pages 8399-8404.
Crossref
Crossref
Yoshiaki Ohtsu, Jacqueline A. Gibbons, Katsuhiro Suzuki, Michael E. Fitzsimmons, Kohei Nozawa & Hiroshi Arai. (2016) Absorption, Distribution, Metabolism, and Excretion of the Androgen Receptor Inhibitor Enzalutamide in Rats and Dogs. European Journal of Drug Metabolism and Pharmacokinetics 42:4, pages 611-626.
Crossref
Crossref
R.E. White. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
1
33
.
Vibeke Hougaard Sunesen. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
177
211
.
Lars Weidolf & Ian D. Wilson. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
141
176
.
Gordon J. Dear & Andrew McEwen. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
45
85
.
Gordon J. Dear & Angus N. R. Nedderman. 2016. Metabolite Safety in Drug Development. Metabolite Safety in Drug Development
17
43
.
Liye Wang, Lingli Huang, Yuanhu Pan, Kamil Kuča, Blanka Klímová, Qinghua Wu, Shuyu Xie, Ijaz Ahmad, Dongmei Chen, Yanfei Tao, Dan Wan, Zhenli Liu & Zonghui Yuan. (2016) Metabolism and Disposition of Aditoprim in Swine, Broilers, Carp and Rats. Scientific Reports 6:1.
Crossref
Crossref
Colby S Shemesh, Rosie Z Yu, Hans J Gaus, Sarah Greenlee, Noah Post, Karsten Schmidt, Michael T Migawa, Punit P Seth, Thomas A Zanardi, Thazha P Prakash, Eric E Swayze, Scott P Henry & Yanfeng Wang. (2016) Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys. Molecular Therapy - Nucleic Acids 5, pages e319.
Crossref
Crossref
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy
307
326
.
Ashley Beattie, Stephen Madden, Chris Lowrie & David MacPherson. (2015) Radiolabeled metabolite and disposition studies in support of safety assessment. Bioanalysis 7:5, pages 507-511.
Crossref
Crossref
Yoshiaki Ohtsu, Takuya Sonoda, Yoko Susaki, Toshifumi Tohda, Yasuhisa Fukunaga, Takafumi Iwatsubo & Kiyoshi Noguchi. (2015) Absorption, distribution, metabolism and excretion of novel phosphodiesterase type 4 inhibitor ASP3258 in rats. Biopharmaceutics & Drug Disposition 36:1, pages 34-48.
Crossref
Crossref
Christian G. Daughton. (2014) Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs. Science of The Total Environment 493, pages 392-404.
Crossref
Crossref
Johanna Haglund, Magnus M. Halldin, Åsa Brunnström, Göran Eklund, Antti Kautiainen, Anna Sandholm & Suzanne L. Iverson. (2014) Pragmatic Approaches to Determine the Exposures of Drug Metabolites in Preclinical and Clinical Subjects in the MIST Evaluation of the Clinical Development Phase. Chemical Research in Toxicology 27:4, pages 601-610.
Crossref
Crossref
Ragu Ramanathan & Dil M. Ramanathan. 2013. Handbook of LC‐MS Bioanalysis. Handbook of LC‐MS Bioanalysis
71
82
.
Steve Unger, Wenkui Li, Jimmy Flarakos & Francis L.S. Tse. 2013. Handbook of LC‐MS Bioanalysis. Handbook of LC‐MS Bioanalysis
1
13
.